✳flâneur — a map of the web's best reading
NewLimit raises $435M led by Founders Fund to bring longevity medicines to human trials
blog.newlimit.com · 454 words · saved by 1 readers
We’ve closed a $435M Series C led by Founders Fund alongside new investors Thrive Capital, Greenoaks, and Quiet Capital, and returning investors Kleiner Perkins, Abstract, Nat Friedman/Daniel Gross, Valor Equity Partners, Eli Lilly Ventures, Human Capital, and others.
Explore this link on the map →